Millburn, NJ, US
Millburn plays a critical role in meeting the growing demand for advanced cancer care to patients across the United States and, upon arrival, Canada.
Ivrea, Italy
RLTCare’s production facility in Italy continues Novartis' commitment to global healthcare, ensuring steady supply of RLTs to patients within Europe, but also to those in the US and beyond.
Zaragoza, Spain
In collaboration with our Italian site, Zaragoza is designed to extend the reach and availability of radioligand therapies outside of the United States.
Indianapolis, IN, US
Purpose-built from the ground up to serve the US and, upon approval, Canada, our latest facility is preparing for line expansion and fully automated lines – an industry first.
